Microparticle generation and leucocyte death in Shiga toxin-mediated HUS

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

(2011) A.-l. Stahl et al.   BLOOD

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia

(2011) Jeffrey J. Pu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis

(2011) M. Morigi et al.   JOURNAL OF IMMUNOLOGY

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

(2011) Edin Colic et al.   LANCET

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clearance of platelet microparticles in vivo

(2011) A. Rank et al.   PLATELETS

Induction of apoptosis by Shiga toxins

(2010) Vernon L Tesh   Future Microbiology

Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration

(2010) Maurizio Brigotti et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

(2010) Samhar I. Al-Akash et al.   PEDIATRIC NEPHROLOGY

Mechanisms of Microparticle Generation: On the Trail of the Mitochondrion!

(2010) Olivier Morel et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom

(2009) C. Mark Taylor et al.   BRITISH JOURNAL OF HAEMATOLOGY

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome

(2009) J. M. Thurman et al.   Clinical Journal of the American Society of Nephrology

Bcl-2 Regulates the Onset of Shiga Toxin 1-Induced Apoptosis in THP-1 Cells

(2009) M.-S. Lee et al.   INFECTION AND IMMUNITY

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

(2009) Dorothea Orth et al.   JOURNAL OF IMMUNOLOGY

Eculizumab for Atypical Hemolytic–Uremic Syndrome

(2009) Jens Nürnberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome

(2009) Anne-lie Ståhl et al.   PLoS One

Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection

(2009) A. Zernecke et al.   Science Signaling

Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials

(2008) Mini Michael et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Interactions between Shiga toxins and human polymorphonuclear leukocytes

(2008) Maurizio Brigotti et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Complement Regulatory Genes and Hemolytic Uremic Syndromes

(2007) David Kavanagh et al.   Annual Review of Medicine